Financial News
Articles published by Travere Therapeutics, Inc.
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
February 28, 2023
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics Announces Proposed Public Offering of Common Stock
February 27, 2023
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results
February 16, 2023
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 13, 2023
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics to Present at Upcoming Investor Conferences
February 08, 2023
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 12, 2023
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics Provides Corporate Update and 2023 Outlook
January 09, 2023
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
Via GlobeNewswire
Tickers
TVTX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.